Caroline Lalet
Caroline Lalet is an expert in Oncology at Institut Bergonié (France). Caroline Lalet has authored 25 publications, the most recent in 2025, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 95 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Geriatrics - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2025
Number : 25
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study. PMID 41233219 — treatment outcome, neoplasms, cohort studies, life expectancy, physicians, therapeutics | J Geriatr Oncol | 2025 | 0 |
| Cognitive remediation in breast cancer survivors: A study protocol. PMID 39987961 — quality of life, cancer survivors, cognitive remediation, breast neoplasms, neoplasms, cognitive dysfunction, breast, cognition disorders, work, research, therapeutics, memory, cognition, memory, episodic | Contemp Clin Trials | 2025 | 0 |
| Health literacy and the use of digital tools in older patients with cancer and their younger counterparts: A multicenter, nationwide study. PMID 39303502 — neoplasms, aged, counseling, patient education as topic, health literacy, literacy | Patient Educ Couns | 2024 | 2 |
| Study protocol for two stepped-wedge interventional trials evaluating the effects of holistic information technology-based patient-oriented management in older multimorbid patients with cancer: The GERONTE trials. PMID 38581958 — neoplasms, aged, multimorbidity, information technology | J Geriatr Oncol | 2024 | 2 |
| One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study. PMID 37297553 — environmental exposure, sars-cov-2, vaccines, antibodies, neoplasms, respect, covid-19, prevalence, severe acute respiratory syndrome-related coronavirus, infections, vaccination hesitancy | Int J Environ Res Public Health | 2023 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Convertases and Pancreatic Cancer Cohort of Patients Treated for Pancreatic Adenocarcinoma NCT06705335 — pancreatic neoplasms, blood, blood specimen collection, neoplasms, adenocarcinoma, biopsy, pancreas, therapeutics, edetic acid | N/A | Recruiting | 2026 |
| Clinical and Dosimetric Study of Patients Treated With 177Lu PSMA 617 for Prostate Cancer NCT06700057 — safety, pharmaceutical preparations, neoplasms, radiopharmaceuticals, prostate, neoplasm metastasis, prostatic neoplasms, nuclear medicine, therapeutics | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map